Skip to content

Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis

Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06806891
Enrollment
40
Registered
2025-02-04
Start date
2024-11-06
Completion date
2025-03-06
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemolysis, Restless Legs Syndrome

Brief summary

the restless leg syndrome is a common complaint in person who undergo hemodialysis. Buddhist walking meditation efficacy was not investigated in those population

Detailed description

the total participants will be 40. all patients will be on hemodialyis. they complain restless leg syndrome. the participants will be divided to group I which received Buddhist walking meditation. this program of meditation will be 30 minutes thrice weekly. before and after buddhist meditation walking, there will be 5 minutes stretching exercises working as warm up or cooling down respectively. the other group will serve as control one .. the number of patient in every group will be 20. the total duration of Buddhist walking meditation will be 12 weeks.

Interventions

BEHAVIORALBuddhist walking meditation

the participants will be on hemodialyis. they complain restless leg syndrome. the participants will receive Buddhist walking meditation. this program of meditation will be 30 minutes thrice weekly. before and after Buddhist walking meditation .. The number of patients in the group will be 20. the total duration of Buddhist walking meditation will be 12 weeks.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* hemodialysis patient (40) * complain of restless leg syndrome * non obese patients

Exclusion criteria

* cardiac patients * chest diseases * mental diseases * hepatic diseases * lower limb orthopedic hurting

Design outcomes

Primary

MeasureTime frameDescription
international RLS Study Group Ratingit will be measured after 12 weeksit will assess the severity of the problem (restless leg syndrome)

Secondary

MeasureTime frameDescription
C reactive proteinIt will be measured after 12 weeksit will be measured in serum
nitric oxideIt will be measured after 12 weeksit will be measured in serum
physical component of short form 12it will be measured after 12 weeksa questionnaire will assess physical abilities of patients
mental component of short form 12it will be measured after 12 weeksa questionnaire will assess mental status of patients
beck depression inventoryIt will be measured after 12 weeksa questionnaire will assess depression status of patients
cortisolIt will be measured after 12 weeksit will be measured in serum
diatolic blood pressureit will be measured after 12 weeksit will be assessed manually
systolic blood pressureit will be measured after 12 weeksit will be assessed manually
Pittsburg sleep quality indexit will be measured after 12 weeksit will assess sleep quality
fatigue severity scaleit will be measured after 12 weeksit will assess fatigue level
sit to stand testit will be measured after 12 weeksit will assess number of sit to stand in 30 seconds
Trait Anxiety Inventoryit will be measured after 12 weeksit will assess anxiety in patients

Countries

Egypt

Contacts

Primary ContactAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
Backup Contactalshymaa abdelazim, lecturer
shimaashaaban30@yahoo.com01033771553

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026